Bone density and structure in long-term survivors of pediatric allogeneic hematopoietic stem cell transplantation
- PMID: 22189761
- PMCID: PMC4540179
- DOI: 10.1002/jbmr.1499
Bone density and structure in long-term survivors of pediatric allogeneic hematopoietic stem cell transplantation
Abstract
Children requiring allogeneic hematopoietic stem cell transplantation (alloHSCT) have multiple risk factors for impaired bone accrual. The impact of alloHSCT on volumetric bone mineral density (vBMD) and cortical structure has not been addressed. Tibia peripheral quantitative computed tomography (pQCT) scans were obtained in 55 alloHSCT recipients, ages 5 to 26 years, a median of 7 (range, 3-16) years after alloHSCT. pQCT outcomes were converted to sex- and race- specific Z-scores relative to age based on reference data in >700 concurrent healthy participants. Cortical section modulus (Zp; a summary measure of cortical bone structure and strength), and muscle and fat area Z-scores were further adjusted for tibia length for age Z-scores. AlloHSCT survivors had lower height Z-scores (-1.21 ± 1.25 versus 0.23 ± 0.92; p < 0.001), versus reference participants; BMI Z-scores did not differ. AlloHSCT survivors had lower trabecular vBMD (-1.05; 95% confidence interval [CI], -1.33 to -0.78; p < 0.001), cortical Zp (-0.63; 95% CI, -0.91 to -0.35; p < 0.001), and muscle (-1.01; 95% CI, -1.30 to -0.72; p < 0.001) Z-scores and greater fat (0.82; 95% CI, 0.54-1.11; p < 0.001) Z-scores, versus reference participants. Adjustment for muscle deficits eliminated Zp deficits in alloHSCT. Total body irradiation (TBI) was associated with lower trabecular vBMD (-1.30 ± 1.40 versus -0.49 ± 0.88; p = 0.01) and muscle (-1.34 ± 1.42 versus -0.34 ± 0.87; p < 0.01) Z-scores. Growth hormone deficiency (GHD) was associated with lower Zp Z-scores (-1.64 ± 2.47 versus -0.28 ± 1.24; p = 0.05); however, muscle differences were not significant (-1.69 ± 1.84 versus -0.78 ± 1.01; p = 0.09). History of graft versus host disease was not associated with pQCT outcomes. In summary, alloHSCT was associated with significant deficits in trabecular vBMD, cortical geometry, and muscle area years after transplantation. TBI and GHD were significant risk factors for musculoskeletal deficits. Future studies are needed to determine the metabolic and fracture implications of these deficits, and to identify therapies to improve bone accrual following alloHSCT during childhood.
Copyright © 2012 American Society for Bone and Mineral Research.
Conflict of interest statement
All authors report no potential past or present conflict of interest.
Figures
References
-
- Sanders J. Bone marrow transplantation in pediatric oncology. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. 3rd. Lippincott-Raven; Philadelphia, PA: 1997. pp. 357–373.
-
- Ballard C, Krance R, Heslop H. Hematopoietic Stem Cell Transplantation in Pediatric Oncology. In: Pizzo P, Poplack D, editors. Principles and Practice of Pediatric Oncology. 5th. Lippincott Williams & Wilkins; Philadelphia: 2006. pp. 476–500.
-
- Atkinson SA, Halton JM, Bradley C, Wu B, Barr RD. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition. Int J Cancer Suppl. 1998;11:35–9. - PubMed
-
- Arekat MR, And G, Lemke S, Moses AM. Dramatic improvement of BMD following vitamin D therapy in a bone marrow transplant recipient. J Clin Densitom. 2002;5(3):267–71. - PubMed
-
- Hartman A, van den Bos C, Stijnen T, Pieters R. Decrease in peripheral muscle strength and ankle dorsiflexion as long-term side effects of treatment for childhood cancer. Pediatr Blood Cancer 2007 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
